Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Authors:
Russell R Kempker
Russell R Kempker
Emory University School of Medicine
United States
Aline B Barth
Aline B Barth
University of Florida
Sergo Vashakidze
Sergo Vashakidze
Emory University School of Medicine
United States
Ketino Nikolaishvili
Ketino Nikolaishvili
National Center for Tuberculosis and Lung Diseases
Nestani Tukvadze
Nestani Tukvadze
National Center for Tuberculosis and Lung Diseases
United States
Nino Bablishvili
Nino Bablishvili
National Center for Tuberculosis and Lung Diseases
Russia
Shota Gogishvili
Shota Gogishvili
Emory University School of Medicine
United States

Antimicrob Agents Chemother 2015 16;59(6):3149-55. Epub 2015 Mar 16.

Division of Infectious Diseases Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA Departments of Epidemiology and Global Health, Emory Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

A better understanding of second-line drug (SLD) pharmacokinetics, including cavitary penetration, may help optimize SLD dosing. Patients with pulmonary multidrug-resistant tuberculosis (MDR-TB) undergoing adjunctive surgery were enrolled in Tbilisi, Georgia. Serum was obtained at 0, 1, 4, and 8 h and at the time of cavitary removal to measure levofloxacin concentrations. After surgery, microdialysis was performed using the ex vivo cavity, and levofloxacin concentrations in the collected dialysate fluid were measured. Noncompartmental analysis was performed, and a cavitary-to-serum levofloxacin concentration ratio was calculated. Twelve patients received levofloxacin for a median of 373 days before surgery (median dose, 11.8 mg/kg). The median levofloxacin concentration in serum (Cmax) was 6.5 μg/ml, and it was <2 μg/ml in 3 (25%) patients. Among 11 patients with complete data, the median cavitary concentration of levofloxacin was 4.36 μg/ml (range, 0.46 to 8.82). The median cavitary/serum levofloxacin ratio was 1.33 (range, 0.63 to 2.36), and 7 patients (64%) had a ratio of >1. There was a significant correlation between serum and cavitary concentrations (r = 0.71; P = 0.01). Levofloxacin had excellent penetration into chronic cavitary TB lesions, and there was a good correlation between serum and cavitary concentrations. Optimizing serum concentrations will help ensure optimal cavitary concentrations of levofloxacin, which may enhance treatment outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00379-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432208PMC
February 2016
28 Reads

Publication Analysis

Top Keywords

cavitary concentrations
12
levofloxacin concentration
8
multidrug-resistant tuberculosis
8
levofloxacin concentrations
8
serum cavitary
8
cavitary penetration
8
levofloxacin
8
correlation serum
8
cavitary
7
concentrations
6
serum
5
vivo cavity
4
performed vivo
4
cavity levofloxacin
4
received levofloxacin
4
patients received
4
levofloxacin median
4
median 373
4
median dose
4
surgery median
4

Similar Publications

Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.

Antimicrob Agents Chemother 2014 18;58(2):782-8. Epub 2013 Nov 18.

Kibong'oto National Tuberculosis Hospital, Kilimanjaro, Tanzania.

Little is known about plasma drug concentrations relative to quantitative susceptibility in patients with multidrug-resistant tuberculosis (MDR-TB). We previously described a TB drug activity (TDA) assay that determines the ratio of the time to detection of plasma-cocultured Mycobacterium tuberculosis versus control growth in a Bactec MGIT system. Here, we assess the activity of individual drugs in a typical MDR-TB regimen using the TDA assay. Read More

View Article
September 2014

Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

Antimicrob Agents Chemother 2017 06 24;61(6). Epub 2017 May 24.

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.

Improved knowledge regarding the tissue penetration of antituberculosis drugs may help optimize drug management. Patients with drug-resistant pulmonary tuberculosis undergoing adjunctive surgery were enrolled. Serial serum samples were collected, and microdialysis was performed using lung tissue to measure pyrazinamide concentrations. Read More

View Article
June 2017

Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.

Antimicrob Agents Chemother 2014 May 18;58(5):2948-51. Epub 2014 Feb 18.

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.

Limited data on fluoroquinolone pharmacokinetics and cardiac effects in children exist. Among 22 children receiving drug-resistant tuberculosis prophylaxis or treatment, serum concentrations following oral doses of levofloxacin (15 mg/kg of body weight) and ofloxacin (20 mg/kg) were lower than those expected from existing pediatric data, possibly due to differences in the formulations (crushed tablets). Drug exposures were lower than those in adults following standard doses and below the proposed pharmacodynamic targets, likely due to more rapid elimination in children. Read More

View Article
May 2014

Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania.

PLoS One 2017 31;12(1):e0170663. Epub 2017 Jan 31.

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, United States of America.

Therapeutic drug monitoring may improve multidrug-resistant tuberculosis (MDR-TB) treatment outcomes. Levofloxacin demonstrates significant individual pharmacokinetic variability. Thus, we sought to develop and validate a high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection for levofloxacin in patients on MDR-TB treatment. Read More

View Article
August 2017